Levima Advanced Materials Past Earnings Performance
Past criteria checks 0/6
Levima Advanced Materials's earnings have been declining at an average annual rate of -12.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 3.2% per year. Levima Advanced Materials's return on equity is 2.8%, and it has net margins of 3.2%.
Key information
-12.8%
Earnings growth rate
-15.7%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 3.2% |
Return on equity | 2.8% |
Net Margin | 3.2% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Levima Advanced Materials makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 6,808 | 220 | 340 | 338 |
30 Jun 24 | 6,884 | 261 | 374 | 341 |
31 Mar 24 | 6,689 | 350 | 375 | 323 |
31 Dec 23 | 6,778 | 446 | 351 | 309 |
30 Sep 23 | 6,676 | 493 | 340 | 307 |
30 Jun 23 | 7,426 | 735 | 333 | 321 |
31 Mar 23 | 8,177 | 906 | 319 | 342 |
01 Jan 23 | 8,157 | 866 | 333 | 331 |
30 Sep 22 | 8,332 | 1,046 | 320 | 342 |
30 Jun 22 | 7,693 | 1,006 | 312 | 323 |
31 Mar 22 | 7,333 | 928 | 338 | 290 |
01 Jan 22 | 7,581 | 1,091 | 320 | 273 |
30 Sep 21 | 7,636 | 1,040 | 448 | 240 |
30 Jun 21 | 7,148 | 952 | 369 | 222 |
31 Mar 21 | 6,561 | 812 | 345 | 197 |
31 Dec 20 | 5,931 | 641 | 304 | 163 |
30 Sep 20 | 5,501 | 533 | 273 | 116 |
31 Dec 19 | 5,674 | 532 | 313 | 25 |
31 Dec 18 | 5,795 | 229 | 260 | 11 |
31 Dec 17 | 4,659 | 55 | 233 | 12 |
31 Dec 16 | 4,017 | 188 | 322 | 8 |
Quality Earnings: 003022 has a large one-off gain of CN¥375.2M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 003022's current net profit margins (3.2%) are lower than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 003022's earnings have declined by 12.8% per year over the past 5 years.
Accelerating Growth: 003022's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 003022 had negative earnings growth (-55.3%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).
Return on Equity
High ROE: 003022's Return on Equity (2.8%) is considered low.